Constellation Pharmaceuticals, Inc. (CNST): Price and Financial Metrics


Constellation Pharmaceuticals, Inc. (CNST): $33.77

-0.05 (-0.15%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

CNST Stock Price Chart Interactive Chart >

Price chart for CNST

CNST Price/Volume Stats

Current price $33.77 52-week high $39.30
Prev. close $33.82 52-week low $17.00
Day low $33.72 Volume 596,292
Day high $33.82 Avg. volume 936,005
50-day MA $24.36 Dividend yield N/A
200-day MA $26.07 Market Cap 1.62B

Constellation Pharmaceuticals, Inc. (CNST) Company Bio


Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapeutics that address serious unmet medical needs in patients with cancers associated with abnormal gene expression or drug resistance. The company’s lead product candidate CPI-1205 that is in Phase Ib/II clinical trials for the treatment of metastatic castration-resistant prostate cancer in combination with androgen receptor signaling inhibitors, as well as for the treatment of solid tumors in combination with immune checkpoint inhibitors. It is also developing CPI-0209, which is in preclinical trials for the treatment of solid tumors and/or hematological malignancies; and CPI-0610 that is in Phase II clinical trials for the treatment of patients with myelofibrosis in combination with ruxolitinib. The company was formerly known as Epigenetix, Inc. and changed its name to Constellation Pharmaceuticals, Inc. in March 2008. The company was founded in 2008 and is based in Cambridge, Massachusetts.


CNST Latest News Stream


Event/Time News Detail
Loading, please wait...

CNST Latest Social Stream


Loading social stream, please wait...

View Full CNST Social Stream

Latest CNST News From Around the Web

Below are the latest news stories about Constellation Pharmaceuticals Inc that investors may wish to consider to help them evaluate CNST as an investment opportunity.

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigation of CNST, USCR, SVBI, and QTS Buyouts

WILMINGTON, Del., June 17, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating: Constellation Pharmaceuticals, Inc. (NASDAQ GS: CNST) regarding possible breaches of fiduciary duties and other violations of law related to Constellation’s agreement to be acquired by MorphoSys AG. Under the terms of the agreement, Constellation’s shareholders will receive $34.00 in cash per share. To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cas

Yahoo | June 17, 2021

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates KIN, CNST, MDP, FMBI; Shareholders are Encouraged to Contact the Firm

NEW YORK, June 17, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Kindred Biosciences, Inc. (NASDAQ: KIN) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Elanco Animal Health Incorporated for $9.25 per share. If you are a Kindred Biosciences shareholder, click here to learn more about your rights and options. Constellation Pharmaceutical

Yahoo | June 17, 2021

SHAREHOLDER ALERT: WeissLaw LLP Reminds FMBI, SLCT, CNST, and DISCA Shareholders About Its Ongoing Investigations

NEW YORK, June 16, 2021 (GLOBE NEWSWIRE) -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua Rubin, Esq.WeissLaw LLP1500 Broadway, 16th FloorNew York, NY 10036(212) 682-3025(888) [email protected] First Midwest Bancorp, Inc. (NASDAQ: FMBI) WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by

Yahoo | June 16, 2021

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates MMAC, ONB, CNST, SLCT; Shareholders are Encouraged to Contact the Firm

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

Yahoo | June 15, 2021

Lifshitz Law Firm, P.C. Announces Investigation of CNST, EQT, FFWM, TGRF, MDP, MMAC, QTS, SLCT, FBNC, USCR

Constellation Pharmaceuticals, Inc. (NasdaqGS: CNST) – MorphoSys AG (NasdaqGS: MOR)

Yahoo | June 12, 2021

Read More 'CNST' Stories Here

CNST Price Returns

1-mo 63.85%
3-mo 20.52%
6-mo -0.82%
1-year 7.72%
3-year N/A
5-year N/A
YTD 17.26%
2020 -38.87%
2019 1,074.81%
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8042 seconds.